EUVIMEDEUVIMED entdecken
Crossref

Mechanistic Model Describing the Time Course of Humoral Immunity Following Ad26.COV2.S Vaccination in Non-Human Primates

Anna Dari iD, Laura Solforosi, Ramon Roozendaal, Richard M W Hoetelmans, Juan-José Pérez-Ruixo iD, Muriel Boulton iD

The Journal of Pharmacology and Experimental Therapeutics · 2023

DOI: 10.1124/jpet.123.001591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2023. Verfasst von Anna Dari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Janssen Research and Development, Beerse, Belgium (A.D., R.M.W.H., J.-J.P.-R., M.B.); and Janssen Vaccines and Prevention B.V., Leiden, The Netherlan…. Hauptthemen laut MEDLINE: Immunity, Humoral, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: ASPR HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mechanistic modeling can be used to describe the time course of vaccine-induced humoral immunity and to identify key biologic drivers in antibody production. We used a six-compartment mechanistic model to describe a 20-week time course of humoral immune responses in 56 non-human primates (NHPs) elicited by vaccination with Ad26.COV2.S according to either a single-dose regimen (1 × 1011 or 5 × 1010 viral particles [vp]) or a two-dose homologous regimen (5 × 1010 vp) given in an interval of 4 or 8 weeks. Humoral immune responses were quantified by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike-specific binding antibody concentrations as determined by spike protein-enzyme-linked immunosorbent assay. The mechanistic model adequately described the central tendency and variability of binding antibody concentrations through 20 weeks in all vaccination arms. The estimation of mechanistic modeling parameters revealed greater contribution of the antibody production mediated by short-lived cells as compared with long-lived cells in driving the peak response, especially post second dose when a more rapid peak response was observed. The antibody production mediated by long-lived cells was identified as relevant for generating the first peak and for contributing to the long-term time course of sustained antibody concentrations in all vaccination arms. The findings contribute evidence on the key biologic components responsible for the observed time course of vaccine-induced humoral immunity in NHPs and constitute a step toward defining immune biomarkers of protection against SARS-CoV-2 that might translate across species. SIGNIFICANCE STATEMENT: We demonstrate the adequacy of a mechanistic modeling approach describing the time course of binding antibody concentrations in non-human primates (NHPs) elicited by different dose levels and regimens of Ad26.COV2.S. The findings are relevant for informing the mechanism-based accounts of vaccine-induced humoral immunity in NHPs and translational research efforts aimed at identifying immune biomarkers of protection against SARS-CoV-2 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, HumoralCOVID-19AnimalsHumansAd26COVS1SARS-CoV-2VaccinationPrimatesAntibodies, Neutralizing

Substanzen

Ad26COVS1Antibodies, Neutralizing

Autor:innen und Institutionen

  • Janssen Research and Development, Beerse, Belgium (A.D., R.M.W.H., J.-J.P.-R., M.B.); and Janssen Vaccines and Prevention B.V., Leiden, The Netherlands (L.S., R.R.) adari1@its.jnj.com.
  • Janssen Research and Development, Beerse, Belgium (A.D., R.M.W.H., J.-J.P.-R., M.B.); and Janssen Vaccines and Prevention B.V., Leiden, The Netherlands (L.S., R.R.).

ORCID-Profile: Anna Dari, Juan-José Pérez-Ruixo, Muriel Boulton

Förderung

  • ASPR HHS

Zitieren

APA

Dari, A., Solforosi, L., Roozendaal, R., Hoetelmans, R. M. W., Pérez-Ruixo, J. J., & Boulton, M. (2023). Mechanistic Model Describing the Time Course of Humoral Immunity Following Ad26.COV2.S Vaccination in Non-Human Primates. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.123.001591

Vancouver

Dari A, Solforosi L, Roozendaal R, Hoetelmans RMW, Pérez-Ruixo JJ, Boulton M. Mechanistic Model Describing the Time Course of Humoral Immunity Following Ad26.COV2.S Vaccination in Non-Human Primates. The Journal of Pharmacology and Experimental Therapeutics. 2023. doi:10.1124/jpet.123.001591

BibTeX
@article{Dari2023,
  author = {Dari, Anna and Solforosi, Laura and Roozendaal, Ramon and Hoetelmans, Richard M W and Pérez-Ruixo, Juan-José and Boulton, Muriel},
  title = {Mechanistic Model Describing the Time Course of Humoral Immunity Following Ad26.COV2.S Vaccination in Non-Human Primates},
  journal = {The Journal of Pharmacology and Experimental Therapeutics},
  year = {2023},
  doi = {10.1124/jpet.123.001591}
}
Kostenlos starten →